文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症甲型H1N1流感患者早期免疫麻痹的临床意义

[Clinical significance of early immunological paralysis in patients with severe H1N1 influenza A].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论重症甲型H1N1流感患者早期即出现免疫麻痹与强烈炎症反应,APACHE II评分、CD4+及CD8+ T细胞是28天死亡的独立危险因素。

该回顾性分析纳入2015年10月至2016年12月南京医科大学附属上海第一人民医院收治的15例重症甲型H1N1流感患者,按28天生存分为存活组(11例)与死亡组(4例)。死亡组APACHE II评分、肌钙蛋白、血尿素氮、CRP、IL-6及B淋巴细胞均高于存活组,血小板、CD3+、CD4+、CD8+ T细胞及NK细胞低于存活组。Cox回归显示APACHE II评分(RR=20.4)、CD4+ T细胞(RR=11.1)和CD8+ T细胞(RR=9.1)是28天生存的独立危险因素。作者认为免疫麻痹和严重炎症反应在重症甲型H1N1流感早期即出现,且与预后显著相关。

要点

  • 死亡组APACHE II评分22.7±3.8 vs 存活组11.8±3.8,肌钙蛋白0.52(0.07,2.02)μg/L vs 0.15(0.10,0.45)μg/L,血尿素氮11.9(6.7,29.1)mmol/L vs 3.9(2.7,6.8)mmol/L,均P<0.05。
  • 死亡组入院24小时内CRP 172.2±88.5 mg/L vs 存活组74.8±33.1 mg/L,IL-6 283.3(140.1,711.0)ng/L vs 18.5(12.7,71.4)ng/L,均P<0.01。
  • 死亡组CD3+ T细胞0.348±0.119 vs 存活组0.573±0.106,CD4+ T细胞0.135±0.046 vs 0.344±0.098,CD8+ T细胞0.089±0.057 vs 0.208±0.054,NK细胞0.124±0.057 vs 0.252±0.182,均P<0.05。
  • Cox回归显示APACHE II评分(RR=20.4,95%CI 5.3-31.2,P=0.017)、CD4+ T细胞(RR=11.1,95%CI 5.1-20.0,P=0.048)、CD8+ T细胞(RR=9.1,95%CI 4.3-16.7,P=0.049)为28天生存独立危险因素。
  • 15例患者中4例28天内死亡,11例治愈出院;死亡组B淋巴细胞0.477±0.136高于存活组0.229±0.121(P<0.01),CD4+/CD8+比值及HLA-DR+ T细胞两组无显著差异(P>0.05)。

适用人群与场景

  • 2015年10月至2016年12月南京医科大学附属上海第一人民医院收治的重症甲型H1N1流感患者15例,按28天生存分为存活组11例与死亡组4例。

处置流程与药物剂量

  • 全部患者均接受抗病毒、抗生素、机械通气及抗凝治疗;部分患者接受俯卧位、神经肌肉阻滞剂及体外膜肺氧合(ECMO)治疗。

研究设计与关键结果

  • 回顾性分析15例重症甲型H1N1流感患者,4例28天内死亡,11例治愈出院。
  • 死亡组APACHE II评分22.7±3.8 vs 存活组11.8±3.8,肌钙蛋白0.52(0.07,2.02)μg/L vs 0.15(0.10,0.45)μg/L,血尿素氮11.9(6.7,29.1)mmol/L vs 3.9(2.7,6.8)mmol/L,均P<0.05。
  • 死亡组入院24小时内CRP 172.2±88.5 mg/L vs 存活组74.8±33.1 mg/L,IL-6 283.3(140.1,711.0)ng/L vs 18.5(12.7,71.4)ng/L,均P<0.01。
  • 死亡组CD3+ T细胞0.348±0.119 vs 存活组0.573±0.106,CD4+ T细胞0.135±0.046 vs 0.344±0.098,CD8+ T细胞0.089±0.057 vs 0.208±0.054,NK细胞0.124±0.057 vs 0.252±0.182,均P<0.05。
  • 死亡组B淋巴细胞0.477±0.136 vs 存活组0.229±0.121(P<0.01);CD4+/CD8+比值1.57±0.26 vs 1.83±0.54及HLA-DR+ T细胞0.035±0.022 vs 0.062±0.036,两组无显著差异(P>0.05)。
  • Cox回归显示APACHE II评分(RR=20.4,95%CI 5.3-31.2,P=0.017)、CD4+ T细胞(RR=11.1,95%CI 5.1-20.0,P=0.048)、CD8+ T细胞(RR=9.1,95%CI 4.3-16.7,P=0.049)为28天生存独立危险因素。

证据类型、等级与局限

  • 证据类型:回顾性分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为免疫麻痹和严重炎症反应在重症甲型H1N1流感早期即出现,且与预后显著相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analysis the immunological characteristics of patients with severe H1N1 influenza A, and to provide theoretical basis for predicting the prognosis of the disease.

METHODS: A retrospective analysis was conducted. The clinical data of 15 patients diagnosed with severe H1N1 influenza A and admitted to Shanghai General Hospital of Nanjing Medical University from October 2015 to December 2016 were collected. All the patients were divided into survival and death groups according to 28-day survival. Clinical characteristics, treatment algorithm, organ function, inflammatory reaction and immune cell status were compared, and Cox regression was used to decide the risk factors of 28-day death in patients with severe H1N1 infection A.

RESULTS: All 15 patients with severe H1N1 infection A were enrolled, most of who presented with cough (93.3%), fever (86.7%), sputum production (80.0%), shortness of breath (73.3%), myalgia (40.0%) and fatigue (40.0%). All had been received anti-virus, antibiotics, mechanical ventilation and anti-coagulation therapy; some were treated with prone position, neuromuscular blocker and extracorporeal membrane oxygenation (ECMO). The incidences of acute myocardial and kidney injury were high, and the acute physiology and chronic health evaluation II (APACHE II) score (14.1±6.1) and sequential organ failure assessment (SOFA) score (9.6±4.1) implicated the critical condition. Of 15 patients, 4 patients died in 28 days, while 11 were cured and discharged. Compared with survival group, the patients in death group had higher levels of APACHE II score (22.7±3.8 vs. 11.8±3.8), troponin [cTn (μg/L): 0.52 (0.07, 2.02) vs. 0.15 (0.10, 0.45)] and blood urea nitrogen [BUN (mmol/L): 11.9 (6.7, 29.1) vs. 3.9 (2.7, 6.8)] and a lower level of blood platelets count [PLT (×109/L): 76±33 vs. 146±49, all P < 0.05]. The levels of C-reactive protein (CRP) and interleukin-6 (IL-6) within 24 hours of admission in death group were significantly higher than those of survival group [CRP (mg/L): 172.2±88.5 vs. 74.8±33.1, IL-6 (ng/L): 283.3 (140.1, 711.0) vs. 18.5 (12.7, 71.4), both P < 0.01]. Compared with survival group, the expressions of CD3+, CD4+, CD8+ T cells and natural killer cell (NK cell) in death group were significantly decreased (CD3+ T cell: 0.348±0.119 vs. 0.573±0.106, CD4+ T cell: 0.135±0.046 vs. 0.344±0.098, CD8+ T cell: 0.089±0.057 vs. 0.208±0.054, NK cell: 0.124±0.057 vs. 0.252±0.182, all P < 0.05), but there were no significant differences in CD4+/CD8+ ratio and human leucocyte antigen-DR positive (HLA-DR+) T cell between death group and survival group (CD4+/CD8+ ratio: 1.57±0.26 vs. 1.83±0.54, HLA-DR+ T cell: 0.035±0.022 vs. 0.062±0.036, both P > 0.05). B lymphocyte in death group was significantly higher than that of survival group (0.477±0.136 vs. 0.229±0.121, P < 0.01). Cox regression analysis revealed that APACHE II score [risk ratio (RR) = 20.4, 95% confidence interval (95%CI) = 5.3-31.2, P = 0.017], CD4+ T cell (RR = 11.1, 95%CI = 5.1-20.0, P = 0.048) and CD8+ T cell (RR = 9.1, 95%CI = 4.3-16.7, P = 0.049) were independently risk factors of 28-day survival of patients with severe H1N1 influenza A.

CONCLUSIONS: Immunological paralysis and severe inflammatory response were early complicated with severe H1N1 influenza A, and these were significantly associated with prognosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Qian Y, Xie H, Tian R, et al. [Clinical significance of early immunological paralysis in patients with severe H1N1 influenza A]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28743332. doi:10.3760/cma.j.issn.2095-4352.2017.07.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。